AZD4360 clinical trials

Study for AZD4360 in Participants With Advanced Solid Tumours

This study is testing a new drug, AZD4360, for people with advanced stomach, bile duct, or pancreatic cancers that have a specific marker called CLDN18.2. It aims to see how safe it is and if it helps shrink tumors.